Publications by authors named "Mario Risi"

Claim this Profile
S
Serum Autoantibody Titers and Neurofilament Light Chain Levels in CASPR2/LGI1 Encephalitis: A Longitudinal Study.
Pietro Businaro, Stefano Masciocchi, Ruggero Barnabei, Silvia Scaranzin, Chiara Morandi, Mario Risi

Neurol Neuroimmunol Neuroinflamm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies.
Sara Carta, Elia Sechi, Alessandro Dinoto, Chiara Mancinelli, Giacomo Greco, Mario Risi

Neurol Neuroimmunol Neuroinflamm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary study.
Rosa Giacca, Miriana Conte, Alessandro d'Ambrosio, Alvino Bisecco, Renato Docimo, Mario Risi

AIMS Neurosci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders.
Stefano Masciocchi, Pietro Businaro, Giacomo Greco, Silvia Scaranzin, Antonio Malvaso, Mario Risi

Neurol Neuroimmunol Neuroinflamm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between biological sex, cognitive reserve, and cognition in multiple sclerosis.
Manuela Altieri, Alvino Bisecco, Alessandro d'Ambrosio, Valentina Rippa, Mario Risi

J Int Neuropsychol Soc· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders.
Stefano Masciocchi, Pietro Businaro, Giacomo Greco, Silvia Scaranzin, Antonio Malvaso, Mario Risi

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal assessment of cognitive function in patients with non-relapsing MOG-IgG associated disease.
Mario Risi, Manuela Altieri, Alvino Bisecco, Valentina Rippa, Riccardo Maria Borgo

J Neurol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis.
Gianpaolo Maggi, Manuela Altieri, Mario Risi, Valentina Rippa, Riccardo Maria Borgo

Mult Scler· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis.
Giacomo Greco, Mario Risi, Stefano Masciocchi, Pietro Businaro, Eleonora Rigoni

J Neurol Neurosurg Psychiatry· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation study.
Gianpaolo Maggi, Manuela Altieri, Mario Risi, Valentina Rippa, Riccardo Maria Borgo

Neurol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment.
Mario Risi, Giacomo Greco, Stefano Masciocchi, Eleonora Rigoni, Elena Colombo

J Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence.
Manuela Altieri, Rosario Domenico Melisi, Miriana Conte, Rocco Capuano, Giovanna Donnarumma, Mario Risi

Neurol Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey.
Manuela Altieri, Rocco Capuano, Alvino Bisecco, Alessandro d'Ambrosio, Mario Risi

Mult Scler Relat Disord· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab.
Rocco Capuano, Giovanna Donnarumma, Alvino Bisecco, Elena Grimaldi, Miriana Conte, Mario Risi

Ther Adv Neurol Disord· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis